Deadline Details

Prescription Monitoring Program PMP Aware
House Bill 2561 from the 2017 legislative session ― the Texas State Board of Pharmacy sunset bill ― mandated that beginning on March 1, 2020, prescribers must check the Texas Prescription Monitoring Program (PMP) before issuing any prescription for four drug classes: opioids, benzodiazepines, barbiturates, and carisoprodol. TMA's advocacy during the session helped delay that mandate until 2019, giving TMA and other interested organizations more time to study how to best combat illicit prescribing.
Beginning March 1, 2020, pharmacists and prescribers (other than a veterinarian) will be required to check the patient’s PMP history before dispensing or prescribing opioids, benzodiazepines, barbiturates, or carisoprodol. Currently, pharmacists and prescribers are encouraged to check the PMP to help eliminate duplicate prescribing and overprescribing of controlled substances, and to obtain critical controlled substance history information. To register, go to
A PMP Aware account allows physicians to check a patient's prescription history for information that indicates illicit activity, drug abuse, drug diversion, and doctor-shopping. It also allows you to receive notifications from the PMP system when it finds evidence of those shady practices. The Texas State Board of Pharmacy creates each account automatically, based on information it receives from state prescriber-overseeing boards such as the Texas Medical Board. However, each prescriber must manually finalize his or her user account. To receive help or instructions from TSBP in setting up your account, call (512) 305-8050 or email